Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ((malignant AND neoplasm AND of AND breast) OR (breast AND cancer AND risk AND factor)):

Search results

Items: 1 to 20 of 11795

1.

Grade-lymph node ratio predicts the survival of breast cancer in different molecular types: A surveillance, epidemiology, and end results population-based analysis.

Liu C, Li H, Zhuo R, Wang L, He L, Ruan Q, Luan X, Mo X, Sun Y.

Medicine (Baltimore). 2019 Jul;98(28):e16436. doi: 10.1097/MD.0000000000016436.

PMID:
31305469
Free Article
2.

[Value of supraclavicular region radiotherapy on patients with pT1-2N1M0 breast cancer after mastectomy].

Shan R, Zhu T, Zhang M, Huang J, Zhou W.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019 Jun 28;44(6):664-671. doi: 10.11817/j.issn.1672-7347.2019.06.009. Chinese.

PMID:
31304928
Free Article
3.

Familial association of lung cancer with liver cancer in first-degree relatives.

Xu CR, Lin H, Su J, Zhang XC, Huang YS, Yang XN, Zhou Q, Yang JJ, Zhong WZ, Wu YL.

Cancer Manag Res. 2019 Jun 28;11:5813-5819. doi: 10.2147/CMAR.S199462. eCollection 2019.

PMID:
31303790
Free Article
4.

The prognosis comparison of different molecular subtypes of breast tumors after radiotherapy and the intrinsic reasons for their distinct radiosensitivity.

He L, Lv Y, Song Y, Zhang B.

Cancer Manag Res. 2019 Jun 28;11:5765-5775. doi: 10.2147/CMAR.S213663. eCollection 2019. Review.

PMID:
31303789
Free Article
5.

Hormone Therapy for Cancer is a Risk Factor for Relapse of Inflammatory Bowel Diseases.

Axelrad JE, Bazarbashi A, Zhou J, Castañeda D, Gujral A, Sperling D, Glass J, Agrawal M, Hong S, Lawlor G, Hudesman D, Chang S, Shah S, Yajnik V, Ananthakrishnan A, Khalili H, Colombel JF, Itzkowitz S; New York Crohn’s and Colitis Organization (NYCCO).

Clin Gastroenterol Hepatol. 2019 Jul 11. pii: S1542-3565(19)30735-9. doi: 10.1016/j.cgh.2019.06.042. [Epub ahead of print]

PMID:
31302306
6.

Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China.

Huang M, Yan C, Xiao J, Wang T, Ling R.

Diagn Pathol. 2019 Jul 12;14(1):74. doi: 10.1186/s13000-019-0849-6.

PMID:
31300059
Free Article
7.

Quantifying the relationship between age at diagnosis and breast cancer-specific mortality.

Johnson HM, Irish W, Muzaffar M, Vohra NA, Wong JH.

Breast Cancer Res Treat. 2019 Jul 11. doi: 10.1007/s10549-019-05353-2. [Epub ahead of print]

PMID:
31297648
8.

A high AR:ERα or PDEF:ERα ratio predicts a sub-optimal response to tamoxifen therapy in ERα-positive breast cancer.

Cao L, Xiang G, Liu F, Xu C, Liu J, Meng Q, Lyu S, Wang S, Niu Y.

Cancer Chemother Pharmacol. 2019 Jul 11. doi: 10.1007/s00280-019-03891-6. [Epub ahead of print]

PMID:
31297554
9.

The use of ultrasonic scalpel lowers the risk of post-mastectomy seroma formation in obese women.

Michalik T, Matkowski R, Biecek P, Szynglarewicz B.

J Cancer. 2019 Jun 9;10(15):3481-3485. doi: 10.7150/jca.29774. eCollection 2019.

PMID:
31293652
Free PMC Article
10.

Reproductive and lifestyle factors and circulating sRANKL and OPG concentrations in women: Results from the EPIC cohort.

Sarink D, Yang J, Johnson T, Chang-Claude J, Overvad K, Olsen A, Tjonneland A, Fournier A, Kvaskoff M, Romana Mancini F, Boeing H, Trichopoulou A, Karakatsani A, Valanou E, Agnoli C, Sacerdote C, Masala G, Mattiello A, Tunino R, van Gils CH, Skeie G, Gram IT, Weiderpass E, Lujan-Barroso L, Petrova D, Santiuste C, Quirós JR, Barricarte A, Amiano P, Travis RC, Gunter MJ, Dossus L, Christakoudi S, Kaaks R, Fortner RT.

Cancer Epidemiol Biomarkers Prev. 2019 Jul 10. pii: cebp.0241.2019. doi: 10.1158/1055-9965.EPI-19-0241. [Epub ahead of print]

PMID:
31292137
11.

Sugary drink consumption and risk of cancer: results from NutriNet-Santé prospective cohort.

Chazelas E, Srour B, Desmetz E, Kesse-Guyot E, Julia C, Deschamps V, Druesne-Pecollo N, Galan P, Hercberg S, Latino-Martel P, Deschasaux M, Touvier M.

BMJ. 2019 Jul 10;366:l2408. doi: 10.1136/bmj.l2408.

PMID:
31292122
Free Article
12.

Metastatic Breast Cancer in Kenya: Presentation, Pathologic Characteristics, and Patterns-Findings From a Tertiary Cancer Center.

Ekpe E, Shaikh AJ, Shah J, Jacobson JS, Sayed S.

J Glob Oncol. 2019 Jul;5:1-11. doi: 10.1200/JGO.19.00036.

PMID:
31291138
13.

Young-onset breast cancer: a poor prognosis only exists in low-risk patients.

Fu J, Wu L, Xu T, Li D, Ying M, Jiang M, Jiang T, Fu W, Wang F, Du J.

J Cancer. 2019 Jun 2;10(14):3124-3132. doi: 10.7150/jca.30432. eCollection 2019.

PMID:
31289582
Free PMC Article
14.
15.

A preliminary report of head-to-head comparison of 18-gene-based clinical-genomic model and oncotype DX 21-gene assay for predicting recurrence of early-stage breast cancer.

Yang PS, Lee YH, Chung CF, Chang YC, Wang MY, Lo C, Tsai LW, Shih KH, Lei J, Yu BL, Cheng SH, Huang CS.

Jpn J Clin Oncol. 2019 Jul 9. pii: hyz102. doi: 10.1093/jjco/hyz102. [Epub ahead of print]

PMID:
31287883
16.

Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis.

Genuino AJ, Chaikledkaew U, The DO, Reungwetwattana T, Thakkinstian A.

Expert Rev Clin Pharmacol. 2019 Jul 9:1-10. doi: 10.1080/17512433.2019.1637252. [Epub ahead of print]

PMID:
31287333
17.

Genetic and molecular biology of breast cancer among Iranian patients.

Moghbeli M.

J Transl Med. 2019 Jul 8;17(1):218. doi: 10.1186/s12967-019-1968-2. Review.

PMID:
31286981
Free Article
18.

The impact of exercise on growth factors (VEGF and FGF2): results from a 12-month randomized intervention trial.

Brenner DR, Ruan Y, Adams SC, Courneya KS, Friedenreich CM.

Eur Rev Aging Phys Act. 2019 Jun 24;16:8. doi: 10.1186/s11556-019-0215-4. eCollection 2019.

PMID:
31285780
Free PMC Article
19.

Effect of obesity, dyslipidemia, and diabetes on trastuzumab-related cardiotoxicity in breast cancer.

Kosalka P, Johnson C, Turek M, Sulpher J, Law A, Botros J, Dent S, Aseyev O.

Curr Oncol. 2019 Jun;26(3):e314-e321. doi: 10.3747/co.26.4823. Epub 2019 Jun 1.

PMID:
31285674
Free PMC Article
20.

The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma.

Grasso S, Cangelosi D, Chapelle J, Alzona M, Centonze G, Lamolinara A, Salemme V, Angelini C, Morellato A, Saglietto A, Bianchi FT, Cabodi S, Salaroglio IC, Fusella F, Ognibene M, Iezzi M, Pezzolo A, Poli V, Di Cunto F, Eva A, Riganti C, Varesio L, Turco E, Defilippi P.

Cell Death Differ. 2019 Jul 8. doi: 10.1038/s41418-019-0386-6. [Epub ahead of print]

PMID:
31285546

Supplemental Content

Loading ...
Support Center